Six current targets were reviewed to calculate the central figure. They include Goldman Sachs at $218, Citi at $228, Guggenheim at $246, B. Riley Securities at $203, Truist at $209, and RBC Capital at $155. The arithmetic mean works out to about $209.83, rounded to a clean $210, with an approximate low-to-high range of $155 to $246. The dispersion matters. Bullish firms such as Guggenheim and Citi emphasize record defense bookings and the coming conversion of missile framework agreements into purchase orders. More cautious views, including RBC's Hold with a $155 target, highlight the timing risk in defense spending and the fact that management's fiscal 2027 revenue target of $950 million-plus sat below the Street's roughly $968 million consensus. Several firms, including B. Riley and RBC, trimmed their targets following the third-quarter report, while Goldman Sachs nudged its target higher. I also checked this using Tickeron’s AI Screener to see how DCO compares to others in the industry.
DCO closed near $145.03 on November 9, 2026, after the shares dropped roughly 15% in the session following third-quarter results released November 5. Reaching $210 would require about a 45% gain, a very large move by almost any measure. The path would likely require the market to re-rate the stock alongside proof that defense orders are actually flowing, because the $210 level was last reached in August 2026 and has since acted as the ceiling. Fundamentals are mixed but improving. Ducommun reported record third-quarter revenue of $227 million, up 5.9% year over year, with adjusted EPS of $1.21 and a record 28.9% gross margin. Commercial aerospace revenue jumped 28%, while military and space revenue declined 7% on order timing. Full-year 2026 revenue guidance was narrowed to $885 million to $890 million.
The $210 area is the most consequential level on the chart: the stock's all-time high of $210.39 was set in August 2026, and the current $210 target sits almost exactly at that prior peak. That makes the target a natural resistance zone that the shares would need to decisively break through. To the downside, the shares have tested the low $150s and traded near their 200-day moving average around $152, a region that has provided periodic support during the recent pullback. The 52-week range spans roughly $85 to $210.
Analyst price targets generally reflect a research horizon of about 12 months, though individual firms apply different assumptions. The next catalysts are the conversion of missile framework agreements into orders, the pace of defense spending and government budgets, further commercial aerospace production-rate increases, and any M&A, which management has flagged as an active priority. Investors should also watch analyst revisions, quarterly margin trends, and whether the $210 prior high is retested with volume rather than on a low-conviction drift. From what I see, these factors will determine if the recovery gains traction.
The $210 central target is an analyst-derived average, not a guarantee, and it coincides with a prior all-time high that has repeatedly capped the shares. Reaching it would require a roughly 45% advance built on tangible defense order conversion, sustained margin expansion, and a re-rating of the aerospace-and-defense group. The bull case rests on record bookings and a strengthening commercial aerospace cycle; the bear case rests on order timing and a 2027 outlook that disappointed the Street. The wide $155-to-$246 analyst range shows that even professionals disagree sharply on the pace of the recovery. Investors should watch order flow, margins, and the $210 resistance level rather than treating the target as a foregone conclusion.
In my own analysis process, Tickeron's AI Daily Buy/Sell Signals have been useful for monitoring names like DCO. The tool applies artificial intelligence to track thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals as conditions shift. It helps surface opportunities and track trends more efficiently, which can be particularly relevant when following volatile aerospace-and-defense stocks alongside broader market moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
The RSI Indicator for DCO moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 14 similar instances when the indicator left oversold territory. In 11 of the 14 cases the stock moved higher. This puts the odds of a move higher at 79%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +9.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where DCO advanced for three days, in 228 of 338 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
DCO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DCO as a result. In 60 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.
The Moving Average Convergence Divergence Histogram (MACD) for DCO turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 30 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The Aroon Indicator for DCO entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. DCO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.958) is normal, around the industry mean (5.050). DCO has a moderately low P/E Ratio (-111.777) as compared to the industry average of (17.247). DCO's Projected Growth (PEG Ratio) (10.790) is slightly higher than the industry average of (3.110). Dividend Yield (0.002) settles around the average of (0.055) among similar stocks. P/S Ratio (3.001) is also within normal values, averaging (18.367).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of aircraft components and equipment
Industry AerospaceDefense